Guided Therapeutics Files Q1 2025 10-Q, Evaluates Tax Disclosures
Ticker: GTHP · Form: 10-Q · Filed: May 15, 2025 · CIK: 924515
| Field | Detail |
|---|---|
| Company | Guided Therapeutics Inc (GTHP) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, tax-disclosures, corporate-actions
Related Tickers: GTHP
TL;DR
GTHP Q1 10-Q filed. Evaluating new tax disclosure rules. No major financial red flags in this snippet.
AI Summary
Guided Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, previously known as Spectrx Inc., is based in Peachtree Corners, GA. The filing includes details on its common stock, par value, and various financial figures, though specific revenue or profit numbers are not immediately apparent in this excerpt. The company is also evaluating the impact of new FASB ASU No. 2023-09 regarding income tax disclosures, effective for periods after December 15, 2024.
Why It Matters
This filing provides insight into the financial structure and reporting obligations of Guided Therapeutics Inc. as it navigates new accounting standards for tax disclosures.
Risk Assessment
Risk Level: medium — The filing contains limited financial details in the provided text, making a full risk assessment difficult, and the company is evaluating new tax disclosure requirements.
Key Numbers
- $0.001 — Par Value (Common Stock par value)
- 500,000,000 — Authorized Shares (Common Stock authorized shares)
- 65,131,000 — Outstanding Shares (Common Stock outstanding shares)
Key Players & Entities
- GUIDED THERAPEUTICS INC (company) — Filer
- SPECTRX INC (company) — Former Company Name
- Peachtree Corners, GA (location) — Business Address
- FASB ASU No. 2023-09 (regulation) — New Accounting Standard
- December 15, 2024 (date) — Effective Date for Tax Disclosures
FAQ
What is the effective date for the new income tax disclosure requirements mentioned in the filing?
The new FASB ASU No. 2023-09, concerning improvements to income tax disclosures, is effective for annual periods beginning after December 15, 2024.
What was Guided Therapeutics Inc. formerly known as?
Guided Therapeutics Inc. was formerly known as Spectrx Inc.
Where is Guided Therapeutics Inc. located?
Guided Therapeutics Inc. is located at 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA 30092.
What is the par value of Guided Therapeutics Inc.'s common stock?
The par value of Guided Therapeutics Inc.'s common stock is $0.001.
When is the period covered by this 10-Q filing?
This 10-Q filing covers the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding GUIDED THERAPEUTICS INC (GTHP).